CS
ORIC icon

Credit Suisse’s Oric Pharmaceuticals ORIC Stock Holding History

Credit Suisse’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17
Closed – – 4207
2022
Q2 		$0 Sell
17
-17,744
-100% -$70.8K ﹤0.01% 4196
2022
Q1 		$94K Sell
17,761
-630
-3% -$5.67K ﹤0.01% 3481
2021
Q4 		$270K Buy
18,391
+2,224
+14% +$34.7K ﹤0.01% 4166
2021
Q3 		$339K Buy
16,167
+3,057
+23% +$62K ﹤0.01% 4036
2021
Q2 		$231K Sell
13,110
-6,226
-32% -$136K ﹤0.01% 4224
2021
Q1 		$473K Sell
19,336
-1,986
-9% -$62.8K ﹤0.01% 3808
2020
Q4 		$722K Buy
+21,322
New +$612K ﹤0.01% 3583

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Credit Suisse's ORIC Position: Q3 2022 in Review

Credit Suisse sold out of Oric Pharmaceuticals (ORIC) in Q3 2022, closing a stake of 17 shares.

Credit Suisse first reported a position in ORIC in Q4 2020 and held it in 7 quarters. The position peaked at $722K in Q4 2020. 76 funds tracked by Wall St. Rank hold ORIC as of Q3 2022.

  • Credit Suisse reported no remaining Oric Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 17 Oric Pharmaceuticals shares in Q3 2022.
  • Credit Suisse first reported a position in Oric Pharmaceuticals in Q4 2020 and held it in 7 quarters.
  • Credit Suisse's Oric Pharmaceuticals position peaked at $722K in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.